MedDataX Logo

Mid-Term Natural Course Postoperative of Crowe Type III-IV Hip Dysplasia

NCT ID: NCT05149729

Last Updated: 2021-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-10

Study Completion Date

2024-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3 and Type 4 hip dysplasia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Crowe type 3 and type 4 patients who underwent shortened hip replacement surgery will be followed up for 2 years.

Patients will be called for routine outpatient controls at the 2nd week, 6th week, 3rd month, 6th month, 12th month, 24th month.

Patients will be referred to the physical therapy specialist for abduction strengthening and pelvis tilt corrective exercises starting from the 6th week.

Scoliosis and orthoroentgenography x-rays will be taken at the last control of the patients.

HHS, WOMAC hip score and SF-12 score will be obtained from the patients. Scores, lower extremity and spine angles will be evaluated after the last examinations performed at 12 and 24 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthropathy Hip Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients over the age of 18 who underwent Crowe Type 3 and Type 4 shortened hip prosthesis
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Crowe type 3 and 4 patients undergoing shortened hip replacement

Clinical and radiological results of Crowe type 3 and 4 patients who underwent shortened hip prosthesis at 12 and 24 months

Group Type EXPERIMENTAL

Shortened hip arthroplasty

Intervention Type PROCEDURE

Crowe type 3 and 4 patients who underwent shortened hip prosthesis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shortened hip arthroplasty

Crowe type 3 and 4 patients who underwent shortened hip prosthesis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement surgery

Exclusion Criteria

* Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement surgery
* Patients who have previously operated on the contralateral hip
* Patients who underwent shortened hip replacement for a reason other than developmental dysplasia of the hip
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bezmialem Vakif University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Murat Sarikas

Orthopaedic surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gökçer Uzer

Role: STUDY_DIRECTOR

Bezmialem Vakif University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bezmialem Vakıf University

Istanbul, Fatih, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

hakan batuhan kaya

Role: CONTACT

Phone: 00905542294339

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hakan Batuhan Kaya

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

https://DOI.ORG/10.1016/J.ARTH.2019.04.028

EFFECTS OF TOTAL HIP ARTHROPLASTY ON AXIAL ALIGNMENT

https://DOI.ORG/10.1016/J.ARTH.2017.05.044

CHANGES IN HIP, KNEE, AND ANKLE CORONAL ALIGNMENTS AFTER TOTAL HIP ARTHROPLASTY WITH TRANSVERSE FEMORAL SHORTENING OSTEOTOMY FOR UNILATERAL CROWE TYPE IV DEVELOPMENTAL DYSPLASIA OF THE HIP

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E.16313

Identifier Type: -

Identifier Source: org_study_id